Efficacy and Safety of Rifaximin Treatment for Reducing the Risk of Overt Hepatic Encephalopathy by Baseline Hepatic Impairment

被引：0
|
作者：
Flamm, Steven L. [1 ]
Bajaj, Jasmohan S. [2 ,3 ]
Heimanson, Zeev [4 ]
Neff, Guy [5 ]
机构：
[1] Northwestern Feinberg, Sch Med, Chicago, IL USA
[2] Virginia Commonwealth Univ, Richmond, VA USA
[3] McGuire VA Med Ctr, Richmond, VA USA
[4] Salix Pharmaceut, Bridgewater, NJ USA
[5] Florida Digest Hlth Specialists, Florida Res Inst, Lakewood Ranch, FL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2018年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
829
引用
收藏
页码：S458 / S460
页数：3
相关论文
共 50 条
  • [41] Efficacy of rifaximin in the different clinical scenarios of hepatic encephalopathy
    Coronel-Castillo, C. E.
    Contreras-Carmona, J.
    Frati-Munari, A. C.
    Uribe, M.
    Mendez-Sanchez, N.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2020, 85 (01): : 56 - 68
  • [42] Efficacy of Rifaximin in Maintenance of Remission in Patients With Hepatic Encephalopathy
    Neff, Guy
    Kemmer, Nyingi
    Gaddis, Amy
    Broda, Taylor
    Kaiser, Tiffany
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S155 - S155
  • [43] Efficacy and Safety of Ornithine Phenylacetate for Treating Overt Hepatic Encephalopathy in a Randomized Trial
    Rahimi, Robert S.
    Safadi, Rifaat
    Thabut, Dominique
    Bhamidimarri, Kalyan Ram
    Pyrsopoulos, Nikolaos
    Potthoff, Amy
    Bukofzer, Stan
    Bajaj, Jasmohan S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (12) : 2626 - +
  • [44] HYPONATREMIA: A RISK FACTOR OF OVERT HEPATIC ENCEPHALOPATHY
    Khedher, S.
    Maoui, A.
    Bouzid, K.
    Lahiani, S.
    Bartkiz, A.
    Salem, M.
    Abdelmoula, J.
    ATHEROSCLEROSIS, 2016, 252 : E86 - E86
  • [45] Efficacy and Safety of Rifaximin in the Prevention of Recurrent Episodes of Hepatic Encephalopathy: A Systematic Review and Meta
    Elmoursi, Ahmed
    Abdelsattar, Ahmed Taha
    Khalil, Farag
    Shabana, Hosam
    Zedan, Hendawy Abdel-Moety
    Mancy, Ismail Mohamed El
    Ramadan, Ibrahim Ghounim
    Mostafa, Sadek
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2023, 34 (06): : 584 - 592
  • [46] Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival
    Gairing, Simon Johannes
    Mangini, Chiara
    Zarantonello, Lisa
    Gioia, Stefania
    Nielsen, Elise Jonasson
    Danneberg, Sven
    Lok, Anna S.
    Sultanik, Philippe
    Galle, Peter Robert
    Labenz, Joachim
    Thabut, Dominique
    Marquardt, Jens Uwe
    Bloom, Patricia P.
    Lauridsen, Mette Munk
    Montagnese, Sara
    Nardelli, Silvia
    Labenz, Christian
    JOURNAL OF INTERNAL MEDICINE, 2024, 295 (03) : 331 - 345
  • [47] Rifaximin and Minimal Hepatic Encephalopathy
    Butterworth, Roger F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (02): : 317 - 318
  • [48] RIFAXIMIN IS EFFICACIOUS IN THE TREATMENT OF CHRONIC OVERT HEPATIC ENCEPHALOPATHY: A UK LIVER MULTI-CENTRE EXPERIENCE
    Patel, V. C.
    Orr, J.
    Sturgeon, J.
    Habtemariam, Z.
    Preedy, H.
    Richardson, P.
    Aspinall, R.
    Hudson, M.
    Shawcross, D. L.
    GUT, 2014, 63 : A14 - A15
  • [49] IMPACT OF UPDATED MORTALITY ESTIMATES ON THE COST-EFFECTIVENESS OF RIFAXIMIN FOR THE TREATMENT OF PATIENTS WITH OVERT HEPATIC ENCEPHALOPATHY
    Bhattacharyya, S.
    John, D.
    Thomas, A.
    Soni, P.
    Jesudian, A. B.
    Dashputre, A. A.
    Joseph, G.
    VALUE IN HEALTH, 2023, 26 (06) : S101 - S101
  • [50] Treatment of Hepatic Encephalopathy with Rifaximin: More to Think About
    Gitlin, Norman
    HEPATOLOGY, 2011, 53 (03) : 1059 - 1059
12345